share_log

Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(61.8%)

Navidea Biopharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-John K. Scott, Jr.(61.8%)

美股SEC公告 ·  2023/12/21 12:32
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息